Open Label, Randomized, Multi-center, Phase 4 Trial to Evaluate the Efficacy and Safety of My-Rept Tablet(Mycophenolate Mofetil 500mg/Tab.) Versus My-Rept Capsule(Mycophenolate Mofetil 250mg/Cap.) in Combination With Tacrolimus for 26 Weeks in Kidney Transplant Patients
Latest Information Update: 22 Aug 2015
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms My-Rept-KT-P4
- Sponsors Chong Kun Dang
- 18 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 07 May 2013 New trial record